Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Trevi Therapeutics Q4 EPS $(0.28) Beats $(0.30) Estimate

Trevi Therapeutics (NASDAQ:TRVI) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.30) by 6.67 percent. This is a 46.15 percent increase over losses of $(0.52) per share from

byBill Haddad

March 17, 2022

1 minute read

Trevi Therapeutics (NASDAQ:TRVI) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.30) by 6.67 percent. This is a 46.15 percent increase over losses of $(0.52) per share from the same period last year.